SCHEMBL1285166

SCHEMBL1285166

O=C(O)CCCCCCCCCCCCCCCC(c1nnn[nH]1)c1nnn[nH]1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.43
LMNA P02545 2/20 0.41
TSHR P16473 2/20 0.41
NFKB1 P19838 1/20 0.41
PMP22 Q01453 1/20 0.41
GSTK1 Q9Y2Q3 2/20 0.41
FFAR4 Q5NUL3 2/20 0.40
FFAR1 O14842 2/20 0.40
ALDH1A1 P00352 2/20 0.39
ENPEP Q07075 1/20 0.37
GPR84 Q9NQS5 2/20 0.36
TBXA2R P21731 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439100 0.85 TBXAS1 (0.38) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL19126676 0.82 ALDH1A1 (0.46) TSHRFFAR4FFAR1ALDH1A1GPR84
SCHEMBL5705372 0.80 MAPT (0.42) TSHRFFAR4FFAR1ALDH1A1GPR84
SCHEMBL16799873 0.77 MAPT (0.37) LMNAFFAR4FFAR1GPR84PPARD
SCHEMBL20659611 0.74 TBXAS1 (0.50) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL1898999 0.74 TBXAS1 (0.50) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL420407 0.74 TBXAS1 (0.50) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL6948576 0.74 GABRP (0.39) LMNATSHRNFKB1ENPEP
SCHEMBL30504236 0.66 GSTK1 (0.71) LMNATSHRNFKB1PMP22GSTK1
SCHEMBL30190004 0.66 GSTK1 (0.71) LMNATSHRNFKB1PMP22GSTK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765408-B1 POLYPEPTIDE PROTRACTING TAGS COMPRISING A TETRAZOLE MOIETY NOVO NORDISK AS (DK) 2015-12-09 EP disclosed
US-9061067-B2 Polypeptide protracting tags NOVO NORDISK A/S (DK) 2015-06-23 US disclosed
EP-2289560-B1 POLYPEPTIDE PROTRACTING TAGS COMPRISING A TETRAZOLE MOIETY NOVO NORDISK AS (DK) 2015-04-22 EP disclosed
US-20120088716-A1 Polypeptide Protracting Tags NOVO NORDISK A/S (DK) 2012-04-12 US disclosed
EP-2292272-A2 Polypeptide protracting tags comprising a tetrazole moiety NOVO NORDISK A/S (DK) 2011-03-09 EP disclosed
EP-2289560-A2 Polypeptide protracting tags comprising a tetrazole moiety NOVO NORDISK A/S (DK) 2011-03-02 EP disclosed
US-20090111730-A1 Polypeptide protracting tags NOVO NORDISK A/S (DK) 2009-04-30 US disclosed
EP-1765408-A2 POLYPEPTIDE PROTRACTING TAGS COMPRISING A TETRAZOLE MOIETY NOVO NORDISK A/S (DK) 2007-03-28 EP disclosed
WO-2006005667-A2 POLYPEPTIDE PROTRACTING TAGS COMPRISING A TETRAZOLE MOIETY NOVO NORDISK A/S (DK) 2006-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088716-A1 Polypeptide Protracting Tags VIP, FGB, NPPA TBXAS1 2115/4885LMNA 527/4885TSHR 351/4885
US-20090111730-A1 Polypeptide protracting tags LNPEP, FGB, ENPEP TBXAS1 2192/4885LMNA 657/4885TSHR 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.